Literature DB >> 308978

Specific suppressive factors produced by hybridomas derived from the fusion of enriched suppressor T cells and a T lymphoma cell line.

M Taniguchi, J F Miller.   

Abstract

A cell fusion technique was used to produce hybridomas between the T lymphoma cell line, EL-4, derived from C57BL (H-2(b)), and an enriched population of human gamma globulin (HGG)-specific suppressor T cells prepared from the spleens of HGG-tolerant CBA mice (H-2(k)). Membrane fluorescence analysis of the hybridoma cells within 6 wk of cell fusion revealed expression of H-2(k) and I-J(k) gene products as well as H-2(b) antigens. Sonicates prepared from hybridomas which contained I-J(k) cells were tested for suppressive activity in vivo in irradiated mice given HGG-primed cells, dinitrophenyl (DNP)-primed cells, HGG-DNP, and horse erythrocytes. Among 18 such hybridoma lines, 6 showed specific suppressive activity, 5 nonspecific suppression, and 7 no suppression. Most lines progressively lost, with time, those properties derived from the normal parent cell. By about 3 mo after fusion few cells expressed CBA markers and only one cell line (number 77) retained some specific suppressive activity. In parallel with the losses was an alteration in chromosome number from near-tetraploid, soon after cell fusion, to near- diploid. Preliminary results with the T lymphoma-sensitive hypoxanthine aminopterin thymidine cell line, L5178, indicate retention of the expression of surface markers derived from the normal parent for 18 wk after hybidization. This suggests that T lymphoma cell lines may have to be screened for their capacity to produce hybridomas with stable properties.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308978      PMCID: PMC2184933          DOI: 10.1084/jem.148.2.373

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  PREPARATION OF PURIFIED ANTI-2,4-DINITROPHENYL ANTIBODIES.

Authors:  H N EISEN
Journal:  Methods Med Res       Date:  1964

2.  Chromosome preparation from fresh and cultured tissues using a modification of the drying technique.

Authors:  M FOX; I M ZEISS
Journal:  Nature       Date:  1961-12-23       Impact factor: 49.962

3.  The effect of isoantibodies in vivo on three different transplantable neoplasms in mice.

Authors:  P A GORER; N KALISS
Journal:  Cancer Res       Date:  1959-09       Impact factor: 12.701

4.  Studies of the culture of leukemic cells in vitro.

Authors:  G A FISCHER
Journal:  Ann N Y Acad Sci       Date:  1958-12-05       Impact factor: 5.691

5.  Hybrid cell lines with T-cell characteristics.

Authors:  R A Goldsby; B A Osborne; E Simpson; L A Herzenberg
Journal:  Nature       Date:  1977-06-23       Impact factor: 49.962

6.  Specific suppression of the immune response by a factor obtained from spleen cells of mice tolerant to human gamma-globulin.

Authors:  M Taniguchi; J F Miller
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

7.  Suppressor T cells in tolerance to non-self and self antigens.

Authors:  A Basten; R Loblay; E Chia; R Callard; H Pritchard-Briscoe
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

8.  Derivation of hybrids between a thymoma line and spleen cells activated in a mixed leukocyte reaction.

Authors:  G Köhler; I Lefkovits; B Elliott; A Coutinho
Journal:  Eur J Immunol       Date:  1977-11       Impact factor: 5.532

9.  Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) III. Immunochemical properties of the GAT-specific suppressive factor.

Authors:  J Theze; J A Kapp; B Benacerraf
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

10.  Enrichment of specific suppressor T cells and characterization of their surface markers.

Authors:  M Taniguchi; J F Miller
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

View more
  25 in total

1.  Production of a T-cell hybrid producing a lymphokine stimulating eosinophil differentiation.

Authors:  D J Warren; C J Sanderson
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

2.  Selection of BW 5147 subclones devoid of non-specific suppressive activity for use in cell hybridization.

Authors:  G Chaouat; M Liacopoulos-Briot; J Couderc; J Parlebas; Y Perrodon; O Briffaut; P Liacopoulos
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

Review 3.  Antigen-specific T-cell factors.

Authors:  M J Taussig
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

Review 4.  T cell clones: their use for the study of specificity, induction, and effector-function of T cells.

Authors:  H von Boehmer; W Haas; H Pohlit; H Hengartner; M Nabholz
Journal:  Springer Semin Immunopathol       Date:  1980-05

5.  Structural analysis of antigen-specific Ia-bearing regulatory T-cell factors: gel electrophoretic analysis of the antigen-specific augmenting T -cell factor.

Authors:  S Miyatani; K Hiramatsu; P B Nakajima; F L Owen; T Tada
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

Review 6.  Helper and suppressor T cell factors.

Authors:  R N Germain; B Benacerraf
Journal:  Springer Semin Immunopathol       Date:  1980-05

7.  Induction, establishment in vitro, and characterization of functional, antigen-specific, carrier-primed murine T-cell lymphomas.

Authors:  O J Finn; J Boniver; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

8.  T-cell hybridomas producing hapten-specific suppressor factors.

Authors:  S Kontiainen; E J Culbert; M Cecka; E Simpson; I F McKenzie; M Feldmann
Journal:  Immunology       Date:  1981-08       Impact factor: 7.397

9.  Acetylcholine receptor-specific suppressive T-cell factor from a retrovirally transformed T-cell line.

Authors:  F Sinigaglia; C Gotti; R Castagnoli; F Clementi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

10.  T-T hybridoma product specifically suppresses tumor immunity.

Authors:  K Nelson; J Cory; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.